STK11 and neoplasm: The loss of STK11/LKB1 causes suppression of stimulator of interferon genes (STING), a reduced expression of type I interferon genes and chemokines that promote T-cell recruitment, and tumour cells appear to lack PD-L1 expression, which altogether can be attributed to immunotherapy resistance79.